Victory Capital Management’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-53
Closed -$19.4K 2522
2023
Q2
$19.4K Sell
53
-1
-2% -$451 ﹤0.01% 2450
2023
Q1
$36.2K Hold
54
﹤0.01% 2469
2022
Q4
$47.1K Hold
54
﹤0.01% 2459
2022
Q3
$59K Sell
54
-10
-16% -$13.2K ﹤0.01% 2546
2022
Q2
$53K Sell
64
-115
-64% -$118K ﹤0.01% 2544
2022
Q1
$175K Buy
179
+5
+3% +$6.75K ﹤0.01% 2430
2021
Q4
$312K Buy
174
+21
+14% +$56.2K ﹤0.01% 2365
2021
Q3
$505K Sell
153
-5
-3% -$17.5K ﹤0.01% 2171
2021
Q2
$695K Buy
158
+97
+159% +$383K ﹤0.01% 2028
2021
Q1
$294K Buy
61
+20
+49% +$113K ﹤0.01% 2405
2020
Q4
$77K Buy
41
+5
+14% +$1.87K ﹤0.01% 2434
2020
Q3
$14K Buy
36
+14
+64% +$5.43K ﹤0.01% 2451
2020
Q2
$7K Buy
22
+5
+29% +$1.26K ﹤0.01% 2481
2020
Q1
$4K Buy
+17
New +$9.6K ﹤0.01% 3511
2019
Q4
Sell
-1
Closed -$1K 2714
2019
Q3
$1K Sell
1
-13
-93% -$14.2K ﹤0.01% 3689
2019
Q2
$20K Hold
14
﹤0.01% 1792
2019
Q1
$35K Hold
14
﹤0.01% 1726
2018
Q4
$43K Hold
14
﹤0.01% 1704
2018
Q3
$65K Buy
+14
New +$59.7K ﹤0.01% 1703

Other funds holding BNGO

Victory Capital Management's BNGO Position: Q3 2023 in Review

Victory Capital Management sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 53 shares — an estimated $19.4K sold.

Victory Capital Management first reported a position in BNGO in Q3 2018 and held it in 19 quarters. The position peaked at $695K in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Victory Capital Management reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Victory Capital Management sold 53 Bionano Genomics shares in Q3 2023, an estimated $19.4K.
  • Victory Capital Management first reported a position in Bionano Genomics in Q3 2018 and held it in 19 quarters.
  • Victory Capital Management's Bionano Genomics position peaked at $695K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Victory Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.